PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Stephen Yoder on Q4 2019 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS)
Q4 2019 Earnings Conference Call
March 12, 2020, 08:00 ET
Company Participants
Thomas Bures - Principal Financial & Accounting Officer & Treasurer
Stephen Yoder - CEO, President & Director
Shane Olwill - SVP & Head, Translational Science
Ingmar Bruns - SVP & Head, Clinical Development
Conference Call Participants
Jonathan Miller - Evercore ISI
Pamela Barendt - Cowen and Company
Jennifer Teubl - Robert W. Baird & Co.
Biren Amin - Jefferies
Matthew Phipps - William Blair & Company
Presentation
Operator
Greetings, and welcome to the Pieris Pharmaceuticals, Inc. Fourth Quarter 2019